银屑病及银屑病关节炎患者循环微小RNA表达模式的识别
该研究通过逆转录定量实时PCR分析血清miRNA表达,在发现阶段检测48份样本(银屑病关节炎、银屑病、对照各16例)的192种miRNA,验证阶段在总共141例(51例银屑病关节炎、40例银屑病、50例对照)中检测17种候选miRNA。发现阶段银屑病中51种、银屑病关节炎中64种miRNA表达下调或上调(33种两者均改变,校正P<0.05);验证阶段9种miRNA可区分患者与对照(AUC≥0.70,均P<0.05),4种miRNA在银屑病与银屑病关节炎间显著差异调控,联合模型区分两者AUC达0.92。
要点
- 银屑病关节炎和银屑病患者血清miRNA表达谱与健康对照不同。
- 验证阶段9种miRNA可区分银屑病关节炎和银屑病与对照(AUC≥0.70,均P<0.05)。
- 4种miRNA联合模型区分银屑病与银屑病关节炎的AUC为0.92。
核心结论
- 银屑病关节炎和银屑病患者血清miRNA表达谱与对照不同。
- 9种miRNA在银屑病关节炎和银屑病患者中差异调控,其中5种既往报道参与骨与软骨代谢,提示银屑病炎症与骨/软骨改变密切相关。
研究设计与样本
- 研究采用逆转录定量实时PCR分析血清miRNA表达,发现阶段在48份样本(银屑病关节炎、银屑病、对照各16例)中检测192种miRNA,验证阶段在总共141例(51例银屑病关节炎、40例银屑病、50例对照)中检测17种选定miRNA。
- 记录人口学与疾病特异性特征及手部MRI影像数据。
主要发现
- 发现阶段银屑病中51种miRNA、银屑病关节炎中64种miRNA表达下调或上调,其中33种两者均改变(校正P<0.05)。
- 验证阶段17种候选miRNA中9种可区分银屑病关节炎和银屑病与对照(AUC≥0.70,均P<0.05)。
- 4种miRNA(miR-19b-3p、miR-21-5p、miR-92a-3p和let-7b-5p)在银屑病与银屑病关节炎间显著差异调控。
- 多变量回归模型中这4种miRNA联合使区分银屑病与银屑病关节炎的AUC增至0.92。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: miRNAs are small non-coding RNAs that control gene expression. Specific intra- and extracellular miRNA signatures have been identified in various diseases. Whether certain miRNA signatures are associated with psoriasis (PsO) and PsA is currently unknown. We aimed to search for circulating miRNA signatures associated with PsO and PsA patients. METHODS: Expression of miRNAs was analysed by reverse transcription quantitative real-time PCR (RT-qPCR) in the serum of PsA, PsO patients and healthy controls. Demographic and disease-specific characteristics and imaging data from hand MRI were recorded. In the discovery phase, 192 miRNA assays were analysed in 48 samples (PsA, PsO, controls: each N = 16). For validation, 17 selected miRNAs were measured in the total population. RESULTS: A total of 141 patients and controls were analysed (51 PsA, 40 PsO, 50 controls). In the discovery phase 51 miRNAs in PsO and 64 miRNAs in PsA were down- or upregulated compared with controls, with 33 miRNAs being changed in both (adj. P < 0.05). The 17 top candidates from discovery were assessed in the validation phase, 9 of them discriminated PsA and PsO from controls [area under the curve (AUC) ≥0.70, all P < 0.05]. Four miRNAs (miR-19b-3p, miR-21-5p, miR-92a-3p and let-7b-5p) were significantly differently regulated between PsO and PsA. A combination of these miRNAs increased the AUC to 0.92 in multivariate regression model to discriminate PsO and PsA. CONCLUSION: miRNA signatures in PsA and PsO patients differ from controls. Nine miRNAs were differentially regulated in PsA and PsO patients, five of them previously reported to be involved in bone and cartilage metabolism, indicating an intimate association of psoriatic inflammation and bone/cartilage changes.
引用
- Haschka J, Simon D, Bayat S, et al. Identification of circulating microRNA patterns in patients in psoriasis and psoriatic arthritis. Rheumatology (Oxford). 2023. PMID: 36734535. doi:10.1093/rheumatology/kead059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。